FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder

Summary
(MedPage Today) -- The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder. Indicated for adults and children weighing at least 15 lb whose...
Description from Medpagetoday.
Who is covering this
-
FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder
(MedPage Today) -- The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder. Indicated for adults and children weighing at least 15 lb whose...






Comments
Comments need JavaScript.